Overview

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Gary Morrow
Collaborator:
National Cancer Institute (NCI)
Treatments:
Dolasetron
Granisetron
Ondansetron
Prochlorperazine